Expected readouts in diabetes, cancer and depression headline a series of study results that could help the biotechnology ...

Shares of Puma Biotechnology, Inc. PBYI have rallied 24% in the past three months against the industry’s decline of 9.7%. The ...

NEW YORK – Anbio Biotechnology filed this week a preliminary prospectus for an initial public offering on the Nasdaq exchange of 1.6 million shares at an anticipated offering price in the range of $5 ...

The United States has scored a decisive victory in its dispute with Mexico over genetically engineered (GE) corn restrictions ...

Anbio Biotechnology filed for a 1.6 million-share initial public offering with the Securities and Exchange Commission. The company said Tuesday it expects the IPO to price between $5 and $6 per share, ...

The lungs are a tempting place for cancer cells -- so much so that more than half of people with advanced cancer elsewh ...

HQH's high yield is unsustainable, relying on capital gains and potentially forcing premature sales. Read why I'm bearish on ...

From proton therapy firsts to tumour-killing quantum dots, Tami Freeman shares her pick of this year’s healthcare innovations ...

Venture capital investors poured billions into the spine surgery industry from 2000 to 2023, according to a study in the January 2025 issue of The Spine Journal ...

Achieving biotech sovereignty will reduce dependency on foreign nations for critical products and technologies, ensuring ...

The year 2025 will witness India assuming critical role in the global biotechnology revolution, and the first Bio-E3 policy ...

This post was written by Luke Carberry Mogan. If you’re looking for biotech stocks to buy, the iShares Biotechnology ETF (NASDAQ:IBB) is an excellent place to start. It tracks the performance of ...